ONMD (OneMedNet) Beta: N/A (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ONMD OneMedNet Corp ONMD
8 GF Score
Price $0.65
GF Value $0.57
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is OneMedNet Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-21), OneMedNet's Beta is Not available.

OneMedNet  (NAS:ONMD) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

OneMedNet Beta Related Terms

OneMedNet Beta Historical Data

* Premium members only.

The historical data trend for OneMedNet's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OneMedNet Beta Chart

OneMedNet Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

OneMedNet Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ONMD
8GF Score
OneMedNet Corp ONMD
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OneMedNet Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is OneMedNet (ONMD) Overvalued in 2026?

Based on GuruFocus' analysis, OneMedNet stock appears to be overvalued. The current stock price of $0.65 is trading 13.9% above its estimated GF Value™ of $0.57. GuruFocus considers OneMedNet to be Modestly Overvalued.

Key valuation signals for ONMD:

  • Beta: N/A
  • GF Value™: $0.57 vs. price of $0.65 (13.9% above fair value)
  • GF Score™: 8/100 with 8 warning signs

No single metric tells the full story. See the ONMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OneMedNet Business Description

Address 6385 Old Shady Oak Road, Suite 250, Eden Prairie, MN, USA, 55344
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.
8GF Score

Get the complete analysis for ONMD

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.57
GF Value